Page last updated: 2024-09-03

1-(4-methoxyphenyl)pyridinium and probenecid

1-(4-methoxyphenyl)pyridinium has been researched along with probenecid in 1 studies

Compound Research Comparison

Studies
(1-(4-methoxyphenyl)pyridinium)
Trials
(1-(4-methoxyphenyl)pyridinium)
Recent Studies (post-2010)
(1-(4-methoxyphenyl)pyridinium)
Studies
(probenecid)
Trials
(probenecid)
Recent Studies (post-2010) (probenecid)
55013,664292375

Protein Interaction Comparison

ProteinTaxonomy1-(4-methoxyphenyl)pyridinium (IC50)probenecid (IC50)
Solute carrier family 22 member 8Mus musculus (house mouse)3.02
Solute carrier family 22 member 6Homo sapiens (human)6.85
Solute carrier family 22 member 8Homo sapiens (human)6.965
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)6.03

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crampton, JM; Lau, YS; Trobough, KL; Wilson, JA1

Other Studies

1 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and probenecid

ArticleYear
Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    General pharmacology, 1990, Volume: 21, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Male; Mice; Mice, Inbred C57BL; Probenecid; Pyridinium Compounds

1990